Penserra Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,520
Closed -$3K 1662
2021
Q3
$3K Buy
+1,520
New +$3.54K ﹤0.01% 1433

Penserra Capital Management's SBBP Position: Q4 2021 in Review

Penserra Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 1,520 shares — an estimated $3K sold.

Penserra Capital Management first reported a position in SBBP in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Penserra Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,520 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $3K.
  • Penserra Capital Management first reported a position in Strongbridge Biopharma plc. in Q3 2021 and held it in 1 quarter.
  • Penserra Capital Management's Strongbridge Biopharma plc. position peaked at $3K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.